Abstract
Objectives: To identify barriers to hydroxyurea adherence (negative beliefs, access, and/or recall barriers), and their relationship to adherence rates and health-related quality of life (HRQOL) among adolescents and young adults (AYA) with sickle cell disease (SCD). Methods: A cross-sectional survey was administered to 34 AYAs (12-22 years old) in SCD clinics from January to December 2015. Study measures included Brief Medication Questionnaire, Modified Morisky Adherence Scale 8-items, visual analog scale, and Patient Reported Outcomes Measurement Information System. Results: Participants (59% male; 91% Black) had a median age of 13.5 years (IQR 12-18). Participants reported negative beliefs (32%), recall barriers (44%), and access barriers (32%). Participants with recall barriers reported worse pain (P=.02), fatigue (P=.05), and depression (P=.05). The number of adherence barriers inversely correlated with adherence level using
Original language | English (US) |
---|---|
Pages (from-to) | 608-614 |
Number of pages | 7 |
Journal | European Journal of Haematology |
Volume | 98 |
Issue number | 6 |
DOIs | |
State | Published - Jun 2017 |
Keywords
- PROMIS
- adherence
- adolescents and young adults
- barriers
- compliance
- health-related quality of life
- hydroxyurea
- patient reported outcomes
- patient reported outcomes measurement information system
- sickle cell
ASJC Scopus subject areas
- Hematology